首页> 外文期刊>Asia-Pacific Biotech News >Danggui Buxue Tang (Chinese Angelica Decoction): A Sample Trial in TCM Standardization
【24h】

Danggui Buxue Tang (Chinese Angelica Decoction): A Sample Trial in TCM Standardization

机译:当归补血汤(中药汤):中药标准化试点

获取原文
获取原文并翻译 | 示例
           

摘要

The major stumbling block on the internationalization of Traditional Chinese Medicine (TCM) is the lack of a complete set of quality standards that can be recognized and accepted by the international community through an objective and stringent validation process. That is to say, Chinese medicine needs to be standardized. Such a standardization is set by the state and the international regulation authorities who demand scientific proof on the safety, quality and efficacy of TCM. By using the simplest TCM formulation, Danggui Buxue Tang, we hereby present some existing problems and strategies to tackle this task based on the uniqueness of Chinese medicines.
机译:中药国际化的主要绊脚石是缺乏一套完整的质量标准,国际社会可以通过客观和严格的验证程序来认可和接受这一标准。也就是说,中药需要标准化。这种标准化是由国家和国际监管机构制定的,它们要求对中药的安全性,质量和功效进行科学证明。通过使用最简单的中药配方当归补血汤,我们在此基于中药的独特性提出了一些现存的问题和解决这一问题的策略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号